{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T21:06:48Z","timestamp":1781989608628,"version":"3.54.5"},"reference-count":19,"publisher":"Society of Nuclear Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.2967\/jnumed.123.266322","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T16:30:13Z","timestamp":1701966613000},"page":"313-319","source":"Crossref","is-referenced-by-count":12,"title":["Tumor Location Relative to the Spleen Is a Prognostic Factor in Lymphoma Patients: A Demonstration from the REMARC Trial"],"prefix":"10.2967","volume":"65","author":[{"given":"Kibrom B.","family":"Girum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-S\u00e9gol\u00e8ne","family":"Cottereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Vercellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Rebaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Clerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Casasnovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Morschhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Thieblemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ir\u00e8ne","family":"Buvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"key":"2024020105551737000_65.2.313.1","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1200\/JCO.21.02063","article-title":"Proposed new dynamic prognostic index for diffuse large B-cell lymphoma: international metabolic prognostic index","volume":"40","author":"Mikhaeel","year":"2022","journal-title":"J Clin Oncol."},{"key":"2024020105551737000_65.2.313.2","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1182\/blood.2019003526","article-title":"High total metabolic tumor volume at baseline predicts survival independent of response to therapy","volume":"135","author":"Vercellino","year":"2020","journal-title":"Blood."},{"key":"2024020105551737000_65.2.313.3","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1182\/bloodadvances.2021006923","article-title":"A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma","volume":"6","author":"Thieblemont","year":"2022","journal-title":"Blood Adv."},{"key":"2024020105551737000_65.2.313.4","first-page":"3055","article-title":"Baseline PET radiomics outperform the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma","volume":"141","author":"Eertink","year":"2023","journal-title":"Blood."},{"key":"2024020105551737000_65.2.313.5","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/hon.3049","article-title":"Dmax: a simple and reliable PET\/CT\u2010derived new biomarker of lymphoma outcome?","volume":"40","author":"Ceriani","year":"2022","journal-title":"Hematol Oncol."},{"key":"2024020105551737000_65.2.313.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.229450"},{"key":"2024020105551737000_65.2.313.7","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s00259-021-05480-3","article-title":"18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma","volume":"49","author":"Eertink","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024020105551737000_65.2.313.8","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.3390\/cancers15092494","article-title":"18F-FDG PET\/CT maximum tumor dissemination (Dmax) in lymphoma: a new prognostic factor?","volume":"15","author":"Albano","year":"2023","journal-title":"Cancers (Basel)."},{"key":"2024020105551737000_65.2.313.9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.annonc.2020.11.019","article-title":"Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET\/CT","volume":"32","author":"Cottereau","year":"2021","journal-title":"Ann Oncol."},{"key":"2024020105551737000_65.2.313.10","doi-asserted-by":"publisher","DOI":"10.1038\/nri1669"},{"key":"2024020105551737000_65.2.313.11","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1200\/JCO.2017.72.6984","article-title":"Lenalidomide maintenance compared with placebo in responding elderly patients with diffuse large B-cell lymphoma treated with first-line rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"35","author":"Thieblemont","year":"2017","journal-title":"J Clin Oncol."},{"key":"2024020105551737000_65.2.313.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.2403"},{"key":"2024020105551737000_65.2.313.13","doi-asserted-by":"crossref","first-page":"e230024","DOI":"10.1148\/ryai.230024","article-title":"TotalSegmentator: robust segmentation of 104 anatomic structures in CT images","volume":"5","author":"Wasserthal","year":"2023","journal-title":"Radiol Artif Intell."},{"key":"2024020105551737000_65.2.313.14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-0125"},{"key":"2024020105551737000_65.2.313.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198710223171718"},{"key":"2024020105551737000_65.2.313.16","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s00259-020-05080-7","article-title":"Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET\/CT for total metabolic tumour volume prediction using a convolutional neural network","volume":"48","author":"Blanc-Durand","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024020105551737000_65.2.313.17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1148\/radiol.2019191114","article-title":"18F-FDG PET\/CT uptake classification in lymphoma and lung cancer by using deep convolutional neural networks","volume":"294","author":"Sibille","year":"2020","journal-title":"Radiology."},{"key":"2024020105551737000_65.2.313.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263501"},{"key":"2024020105551737000_65.2.313.19","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s10278-020-00341-1","article-title":"Tumor segmentation and feature extraction from whole-body FDG-PET\/CT using cascaded 2D and 3D convolutional neural networks","volume":"33","author":"Jemaa","year":"2020","journal-title":"J Digit Imaging."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.123.266322","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T13:58:30Z","timestamp":1706795910000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.123.266322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,1]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.2967\/jnumed.123.266322"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.123.266322","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,7]]}}}